Flora Growth Corp. (FLGC) Financials
Stock symbol FLGC is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker FLGC was renamed to
ZSTK
effective 2026-01-29.
FLGC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 74.0 million | 9.1 million |
| June 30, 2025 | 22.7 million | 18.6 million |
| March 31, 2025 | 22.4 million | 17.6 million |
| Dec. 31, 2024 | 26.2 million | 21.7 million |
FLGC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | -309570 | 541000 |
| June 30, 2025 | -3.0 million | 172000 |
| March 31, 2025 | -2.8 million | 172000 |
| Dec. 31, 2024 | -1.3 million | 2.4 million |
FLGC Net Income
No data available :(
FLGC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | 13.1 million | 307000 | 484000 |
| June 30, 2025 | 1.5 million | 4.0 million | 2.8 million |
| March 31, 2025 | 3.7 million | 4.2 million | 3.0 million |
| Dec. 31, 2024 | 6.0 million | 2.0 million | 2.8 million |
FLGC Shares Outstanding
FLGC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | 428155 | 52000 | 2.7 million | - |
| June 30, 2025 | 65000 | 73000 | 4.9 million | 945000 |
| March 31, 2025 | 24000 | 113000 | 4.2 million | 905000 |
| Dec. 31, 2024 | 2375 | 191000 | 7.8 million | 1.9 million |
FLGC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | 9.7 million | 9.4 million |
| June 30, 2025 | 14.8 million | 12.0 million |
| March 31, 2025 | 11.8 million | 8.9 million |
| Dec. 31, 2024 | 13.3 million | 10.7 million |
FLGC
Price: $8.95
52 week price:
Earnings Per Share: -41.09 USD
P/E Ratio: -0.19
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 2.7 million
Market Capitalization: 4.2 million